Dora L.�W. Kwong

17.0k total citations · 3 hit papers
219 papers, 11.1k citations indexed

About

Dora L.�W. Kwong is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Surgery. According to data from OpenAlex, Dora L.�W. Kwong has authored 219 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Pulmonary and Respiratory Medicine, 83 papers in Otorhinolaryngology and 80 papers in Surgery. Recurrent topics in Dora L.�W. Kwong's work include Head and Neck Cancer Studies (81 papers), Head and Neck Surgical Oncology (30 papers) and Esophageal Cancer Research and Treatment (26 papers). Dora L.�W. Kwong is often cited by papers focused on Head and Neck Cancer Studies (81 papers), Head and Neck Surgical Oncology (30 papers) and Esophageal Cancer Research and Treatment (26 papers). Dora L.�W. Kwong collaborates with scholars based in Hong Kong, China and United States. Dora L.�W. Kwong's co-authors include Jonathan S. T. Sham, Daniel T. T. Chua, Gordon K.�H. Au, WI Wei, Ehn Pow, Lucullus H.T. Leung, Xin‐Yuan Guan, V. Wu, WK Leung and Anne S. McMillan and has published in prestigious journals such as JAMA, Nature Medicine and Nature Communications.

In The Last Decade

Dora L.�W. Kwong

214 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma

2008 1.3k citations Dora L.�W. Kwong et al. profile →
Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial

2006 543 citations Dora L.�W. Kwong, Jonathan S. T. Sham et al. International Journal of Radiation Oncology*Biology*Physics profile →
Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience

2005 482 citations Stewart Y. Tung, Dora L.�W. Kwong et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dora L.�W. Kwong Hong Kong	53	4.1k	3.5k	3.4k	3.3k	3.0k	219	11.1k
David Raben United States	48	5.2k 1.3×	3.7k 1.0×	6.8k 2.0×	4.4k 1.3×	5.6k 1.8×	236	15.2k
Anne W.M. Lee China	48	5.7k 1.4×	3.8k 1.1×	3.7k 1.1×	1.4k 0.4×	3.1k 1.0×	173	9.5k
John Waldron Canada	51	4.2k 1.0×	2.9k 0.8×	2.6k 0.7×	1.6k 0.5×	2.3k 0.8×	266	8.0k
Wilfried Budach Germany	51	1.8k 0.4×	3.6k 1.0×	2.7k 0.8×	1.8k 0.5×	4.5k 1.5×	334	10.4k
K. Kian Ang United States	54	5.3k 1.3×	3.9k 1.1×	4.2k 1.2×	1.8k 0.6×	4.5k 1.5×	177	11.6k
Anthony J. Cmelak United States	36	5.9k 1.5×	3.8k 1.1×	3.4k 1.0×	1.5k 0.4×	2.7k 0.9×	145	9.3k
Theodoros N. Teknos United States	58	4.5k 1.1×	4.1k 1.1×	3.5k 1.0×	2.6k 0.8×	2.2k 0.7×	231	10.9k
Richard J. Wong United States	57	3.3k 0.8×	3.8k 1.1×	3.6k 1.1×	1.7k 0.5×	2.1k 0.7×	293	10.3k
Wai Tong Ng China	40	3.7k 0.9×	2.4k 0.7×	2.6k 0.7×	1.2k 0.4×	2.0k 0.6×	154	6.3k
Gregory T. Wolf United States	70	10.9k 2.7×	7.9k 2.2×	8.2k 2.4×	4.2k 1.3×	5.4k 1.8×	343	20.9k

Countries citing papers authored by Dora L.�W. Kwong

Since Specialization

Citations

This map shows the geographic impact of Dora L.�W. Kwong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora L.�W. Kwong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora L.�W. Kwong more than expected).

Fields of papers citing papers by Dora L.�W. Kwong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dora L.�W. Kwong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora L.�W. Kwong. The network helps show where Dora L.�W. Kwong may publish in the future.

Co-authorship network of co-authors of Dora L.�W. Kwong

This figure shows the co-authorship network connecting the top 25 collaborators of Dora L.�W. Kwong. A scholar is included among the top collaborators of Dora L.�W. Kwong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora L.�W. Kwong. Dora L.�W. Kwong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kam, Ngar‐Woon, Valen Zhuoyou Yu, Wenlan Qiu, et al.. (2025). Cell-associated galectin 9 interacts with cytotoxic T cells confers resistance to tumor killing in nasopharyngeal carcinoma through autophagy activation. Cellular and Molecular Immunology. 22(3). 260–281. 4 indexed citations

Chan, Wing‐Lok, Huiqing Hou, Cheuk‐Wai Choi, et al.. (2025). Development and validation of ACTTOP: a prediction model for severe anticancer treatment toxicities in older patients with solid malignancy. Age and Ageing. 54(11). 1 indexed citations

Zhou, Hong-Yu, Licheng Tan, Baifeng Zhang, et al.. (2024). GPRC5A promotes lung colonization of esophageal squamous cell carcinoma. Nature Communications. 15(1). 9950–9950. 2 indexed citations

Chan, Wing‐Lok, Xiaoqing Liu, Brian J. Yun, et al.. (2024). Digital Rehabilitation Program for Breast Cancer Survivors on Adjuvant Hormonal Therapy: A Feasibility Study. Cancers. 16(23). 4084–4084.

Chan, Wing‐Lok, Carlos King Ho Wong, Yhi Wong, et al.. (2023). Adjuvant Chemotherapy in Older Patients with Gastric Cancer: A Population-Based Cohort Study. Cancers. 15(15). 3768–3768. 2 indexed citations

Ko, Josephine Mun Yee, Ka On Lam, Dora L.�W. Kwong, et al.. (2023). Circulating Tumor Cell Enumeration for Serial Monitoring of Treatment Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma. Cancers. 15(3). 832–832. 10 indexed citations

Chiang, Chi‐Leung, Tai‐Chung Lam, Aya El Helali, et al.. (2023). Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial. The Lancet Regional Health - Western Pacific. 40. 100898–100898. 7 indexed citations

Chan, Wing‐Lok, Cheuk‐Wai Choi, Brian Hung‐Hin Lang, et al.. (2021). Health-Related Quality of Life in Asian Differentiated Thyroid Cancer Survivors. Cancer Control. 28. 2895447774–2895447774. 25 indexed citations

Jiang, Chen, Lei Li, Yan‐Qun Xiang, et al.. (2020). Epstein–Barr Virus miRNA BART2-5p Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing RND3. Cancer Research. 80(10). 1957–1969. 33 indexed citations

10.

Ko, Josephine Mun Yee, Ka On Lam, K.W. Chiu, et al.. (2020). Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell Carcinoma. Cancers. 12(6). 1352–1352. 13 indexed citations

11.

Lam, Ka-On & Dora L.�W. Kwong. (2018). Target Therapy for Esophageal Adenocarcinoma. Methods in molecular biology. 1756. 51–65. 2 indexed citations

12.

Ng, Wai Tong, Roger K.C. Ngan, Dora L.�W. Kwong, et al.. (2017). Phase 2 Multicenter Trial Evaluating the Role of Induction TPF Followed by Weekly Docetaxel and Cetuximab in Combination With IMRT for Locally Recurrent Nasopharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 99(2). E351–E352. 1 indexed citations

13.

Yuan, Chuang, V. Wu, Shea Ping Yip, Dora L.�W. Kwong, & Michael Ying. (2014). Predictors of the Extent of Carotid Atherosclerosis in Patients Treated with Radiotherapy for Nasopharyngeal Carcinoma. PLoS ONE. 9(12). e116284–e116284. 13 indexed citations

14.

Kwok, Hoi‐Hin, Chunhui Wu, Anne Palser, et al.. (2014). Genomic Diversity of Epstein-Barr Virus Genomes Isolated from Primary Nasopharyngeal Carcinoma Biopsy Samples. Journal of Virology. 88(18). 10662–10672. 86 indexed citations

15.

Smith, Corey, Janice Tsang, Leone Beagley, et al.. (2012). Effective Treatment of Metastatic Forms of Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy. Cancer Research. 72(5). 1116–1125. 135 indexed citations

16.

Kwok, Hin, Amy H.Y. Tong, Si Lok, et al.. (2012). Genomic Sequencing and Comparative Analysis of Epstein-Barr Virus Genome Isolated from Primary Nasopharyngeal Carcinoma Biopsy. PLoS ONE. 7(5). e36939–e36939. 75 indexed citations

17.

Kong, Kar Lok, Dora L.�W. Kwong, Li Fu, et al.. (2010). Characterization of a Candidate Tumor Suppressor Gene Uroplakin 1A in Esophageal Squamous Cell Carcinoma. Cancer Research. 70(21). 8832–8841. 38 indexed citations

18.

Qin, Yanru, Hong Tang, Fajun Xie, et al.. (2010). Characterization of Tumor-Suppressive Function of SOX6 in Human Esophageal Squamous Cell Carcinoma. Clinical Cancer Research. 17(1). 46–55. 57 indexed citations

19.

Law, Simon, Dora L.�W. Kwong, Ka–Fai Kwok, et al.. (2003). Improvement in Treatment Results and Long-Term Survival of Patients With Esophageal Cancer. Annals of Surgery. 238(3). 339–348. 136 indexed citations

20.

Kwong, Dora L.�W., WI Wei, Ashley Cheng, et al.. (2001). Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma. Cancer. 91(6). 1105–1113. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact